FDA unveils rules for bespoke gene therapies, predicting flood of rare disease applications Guidance on ‘plausible mechanism pathway’ includes limits, though questions remain on scope

https://www.statnews.com/2026/02/23/fda-rare-disease-new-guidelines-plausible-mechanism-pathway/ By Jason Mast and Lizzy LawrenceFeb. 23, 2026